Suzanne S. Eveland

1.1k total citations
16 papers, 756 citations indexed

About

Suzanne S. Eveland is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Suzanne S. Eveland has authored 16 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Suzanne S. Eveland's work include Drug Transport and Resistance Mechanisms (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Suzanne S. Eveland is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Suzanne S. Eveland collaborates with scholars based in United States and Australia. Suzanne S. Eveland's co-authors include Matt S. Anderson, Christian R.H. Raetz, David L. Pompliano, Sheryl A. Hyland, Theresa M. Kelly, Lynn L. Silver, Katherine Young, David Bramhill, Patricia M. Cameron and Hiroshi Ōnishi and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

Suzanne S. Eveland

16 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne S. Eveland United States 13 476 268 164 114 109 16 756
Sheryl A. Hyland United States 12 374 0.8× 179 0.7× 211 1.3× 151 1.3× 55 0.5× 12 709
Holger Paulsen Germany 13 610 1.3× 159 0.6× 262 1.6× 107 0.9× 61 0.6× 23 1.1k
M.T. Hilgers United States 15 686 1.4× 147 0.5× 136 0.8× 162 1.4× 75 0.7× 17 1.1k
Nina Brunner Germany 15 582 1.2× 132 0.5× 164 1.0× 116 1.0× 114 1.0× 21 1.0k
Victoria Jones United States 16 501 1.1× 112 0.4× 221 1.3× 109 1.0× 26 0.2× 19 1.0k
E. Jeffrey North United States 19 735 1.5× 119 0.4× 328 2.0× 162 1.4× 33 0.3× 29 1.5k
Lynn Miesel United States 17 440 0.9× 125 0.5× 109 0.7× 178 1.6× 23 0.2× 28 825
Astrid Zervosen Belgium 21 543 1.1× 101 0.4× 405 2.5× 239 2.1× 57 0.5× 40 1.0k
Nanette L. S. Que United States 13 302 0.6× 62 0.2× 121 0.7× 39 0.3× 46 0.4× 17 570

Countries citing papers authored by Suzanne S. Eveland

Since Specialization
Citations

This map shows the geographic impact of Suzanne S. Eveland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne S. Eveland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne S. Eveland more than expected).

Fields of papers citing papers by Suzanne S. Eveland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne S. Eveland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne S. Eveland. The network helps show where Suzanne S. Eveland may publish in the future.

Co-authorship network of co-authors of Suzanne S. Eveland

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne S. Eveland. A scholar is included among the top collaborators of Suzanne S. Eveland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne S. Eveland. Suzanne S. Eveland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sweis, Ramzi F., Julianne A. Hunt, Peter M. Sinclair, et al.. (2011). 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: Attenuation of hERG binding and improved HDLc-raising efficacy. Bioorganic & Medicinal Chemistry Letters. 21(9). 2597–2600. 11 indexed citations
2.
Chen, Zhu, Edward A. O’Neill, Roger Meurer, et al.. (2011). Reconstituted HDL Elicits Marked Changes in Plasma Lipids Following Single-Dose Injection in C57Bl/6 Mice. Journal of Cardiovascular Pharmacology and Therapeutics. 17(3). 315–323. 19 indexed citations
3.
Thompson, Christopher F., Amjad Ali, Zhijian Lu, et al.. (2011). Discovery of Substituted Biphenyl Oxazolidinone Inhibitors of Cholesteryl Ester Transfer Protein. ACS Medicinal Chemistry Letters. 2(6). 424–427. 11 indexed citations
4.
Lu, Zhijian, Ashleigh B. Theberge, Amjad Ali, et al.. (2010). Design of a novel class of biphenyl CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(24). 7469–7472. 11 indexed citations
5.
Sweis, Ramzi F., Julianne A. Hunt, Milton L. Hammond, et al.. (2010). 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: Scaffold design and advancement in HDLc-raising efficacy. Bioorganic & Medicinal Chemistry Letters. 21(6). 1890–1895. 15 indexed citations
6.
Hunt, Julianne A., Milton L. Hammond, James V. Pivnichny, et al.. (2009). 2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety. Bioorganic & Medicinal Chemistry Letters. 20(3). 1019–1022. 19 indexed citations
7.
Smith, Cameron J., Amjad Ali, Liya Chen, et al.. (2009). 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety. Bioorganic & Medicinal Chemistry Letters. 20(1). 346–349. 33 indexed citations
8.
Eveland, Suzanne S., Denise P. Milot, Qiu Guo, et al.. (2007). A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology. Analytical Biochemistry. 368(2). 239–249. 13 indexed citations
9.
Anderson, Matt S., Suzanne S. Eveland, & Neil P. J. Price. (2000). Conserved cytoplasmic motifs that distinguish sub-groups of the polyprenol phosphate:N-acetylhexosamine-1-phosphate transferase family. FEMS Microbiology Letters. 191(2). 169–175. 45 indexed citations
10.
Leiting, Barbara, KellyAnn D. Pryor, Suzanne S. Eveland, & Matt S. Anderson. (1998). One-Day Enzymatic Synthesis and Purification of UDP–N- [1-14C]Acetyl-Glucosamine. Analytical Biochemistry. 256(2). 185–191. 13 indexed citations
11.
12.
Hyland, Sheryl A., Suzanne S. Eveland, & Matt S. Anderson. (1997). Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway. Journal of Bacteriology. 179(6). 2029–2037. 36 indexed citations
13.
Lutkenhaus, Joe, et al.. (1996). Regulation of UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine Deacetylase in Escherichia coli. Journal of Biological Chemistry. 271(42). 25898–25905. 74 indexed citations
14.
Anderson, Matt S., Suzanne S. Eveland, Hiroshi Ōnishi, & David L. Pompliano. (1996). Kinetic Mechanism of the Escherichia coli UDPMurNAc-Tripeptide d-Alanyl-d-alanine-Adding Enzyme:  Use of a Glutathione S-Transferase Fusion. Biochemistry. 35(50). 16264–16269. 74 indexed citations
15.
Young, Katherine, Lynn L. Silver, David Bramhill, et al.. (1995). The envA Permeability/Cell Division Gene of Escherichia coli Encodes the Second Enzyme of Lipid A Biosynthesis. Journal of Biological Chemistry. 270(51). 30384–30391. 157 indexed citations
16.
Kelly, Theresa M., et al.. (1994). An Escherichia coli gene (FabZ) encoding (3R)-hydroxymyristoyl acyl carrier protein dehydrase. Relation to fabA and suppression of mutations in lipid A biosynthesis. Journal of Biological Chemistry. 269(52). 32896–32903. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026